Department of Vascular Surgery, Liuzhou People's Hospital, Liuzhou, 545006, China.
Department of Neurosurgery, Liuzhou People's Hospital, No. 8 Wenchang Road, Liuzhou, 545006, China.
Sleep Breath. 2021 Mar;25(1):227-236. doi: 10.1007/s11325-020-02096-z. Epub 2020 May 12.
Previous studies suggest a relationship between sleep disordered breathing (SDB) and lower extremity artery disease (LEAD) though disagreements remain. This study was performed to assess the association between SDB and LEAD in a metaanalysis.
PubMed and Embase databases were searched for observational studies. A random-effects model incorporating between-study heterogeneity was used to pool the data.
The search revealed 7 studies including 152,885 participants. Patients with SDB had higher odds of LEAD (risk ratio [RR] = 1.32, 95% confidence interval [CI] = 1.07 to 1.63, p = 0.01, I = 66%) compared to non-SDB participants. In subgroup analyses, SDB was related to higher odds of LEAD in patients with stroke or diabetes (RR = 3.28, p < 0.001) than in a community-derived population (RR = 1.17, p = 0.08; p for subgroup difference < 0.001). Furthermore, the odds of LEAD was increased in patients with moderate (RR = 1.34, 95% CI = 1.04 to 1.73, p = 0.02) or severe SDB (RR = 1.81, 95% CI = 1.08 to 3.03, p = 0.02), but not in those with mild SDB (RR = 0.94, 95% CI = 0.69 to 1.29, p = 0.71). Differences in study design or methods for LEAD diagnosis did not appear to affect the association between SDB and LEAD.
Patients with SDB have higher odds of LEAD compared to non-SDB participants.
既往研究提示睡眠呼吸障碍(SDB)与下肢动脉疾病(LEAD)之间存在相关性,但仍存在争议。本研究旨在通过荟萃分析评估 SDB 与 LEAD 之间的关联。
检索 PubMed 和 Embase 数据库中的观察性研究。采用包含研究间异质性的随机效应模型对数据进行合并。
检索共发现 7 项研究,包含 152885 名参与者。与非 SDB 参与者相比,SDB 患者 LEAD 的患病风险更高(风险比 [RR] = 1.32,95%置信区间 [CI] = 1.07 至 1.63,p = 0.01,I² = 66%)。亚组分析显示,与社区人群(RR = 1.17,p = 0.08;p 组间差异<0.001)相比,SDB 与卒中或糖尿病患者 LEAD 的患病风险更高(RR = 3.28,p < 0.001)。此外,中重度 SDB(RR = 1.34,95%CI = 1.04 至 1.73,p = 0.02)患者 LEAD 的患病风险增加,但轻度 SDB 患者(RR = 0.94,95%CI = 0.69 至 1.29,p = 0.71)的患病风险未增加。LEAD 诊断的研究设计或方法的差异似乎并未影响 SDB 与 LEAD 之间的关联。
与非 SDB 参与者相比,SDB 患者 LEAD 的患病风险更高。